Forskning ved Københavns Universitet - Københavns Universitet

Forside

Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion)

Publikation: Bidrag til tidsskriftTidsskriftartikelRådgivningfagfællebedømt

Standard

Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97 : (Scientific Opinion). / EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA).

I: E F S A Journal, Bind 15, Nr. 11, 5057, 17.11.2017.

Publikation: Bidrag til tidsskriftTidsskriftartikelRådgivningfagfællebedømt

Harvard

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2017, 'Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion)', E F S A Journal, bind 15, nr. 11, 5057. https://doi.org/10.2903/j.efsa.2017.5057

APA

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2017). Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion). E F S A Journal, 15(11), [5057]. https://doi.org/10.2903/j.efsa.2017.5057

Vancouver

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion). E F S A Journal. 2017 nov 17;15(11). 5057. https://doi.org/10.2903/j.efsa.2017.5057

Author

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). / Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97 : (Scientific Opinion). I: E F S A Journal. 2017 ; Bind 15, Nr. 11.

Bibtex

@article{3ccc018549a24ddf9b00b4d0c1f942a7,
title = "Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97: (Scientific Opinion)",
abstract = "Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on betaine as a novel food (NF) pursuant to Regulation (EC) No 258/97. The information provided on the composition, the specifications, the batch-to-batch variability, stability and production process of the NF is sufficient and does not raise concerns about the safety of the NF. The NF is proposed to be used in foods intended to meet additional requirements for intense muscular effort with a maximum intake of 2.5 g/day of betaine for sports people above 10 years of age. Based on the lowest BMDL05, which was derived from a chronic toxicity study in rats in which a dose-related increase in platelet counts was observed, and the anticipated daily intake of the NF in the target population, the Margins of Exposure are 3.6 and 5, which are generally regarded as not sufficient. However, the total exposure to betaine from the diet (about 830 mg/day) is not known to be associated with adverse effects. Moreover, no adverse effects on platelet counts were noted in human intervention studies with exposure levels of 4 g/day of betaine for up to 6 months. A significant increase in total and low-density lipoprotein (LDL)-cholesterol concentrations was noted at intakes of 4 g/day of betaine in overweight subjects with metabolic syndrome but not in healthy subjects, nor at intakes of 3 g/day. Thus, considering 4 g/day of betaineas a reference point and applying an uncertainty factor of 10 to account for interindividual variability, an amount of 400 mg/day of betaine in addition to the background exposure is considered as safe. The Panel considers that the NF is safe to be used at maximum intake of 400 mg/day in the target population.",
keywords = "Faculty of Science, Betaine, Novel food, Ingredient, Safety",
author = "{EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)} and Sj{\"o}din, {Anders Mikael}",
note = "EFSA 2017 5057",
year = "2017",
month = nov,
day = "17",
doi = "10.2903/j.efsa.2017.5057",
language = "English",
volume = "15",
journal = "E F S A Journal",
issn = "1831-4732",
publisher = "European Food Safety Authority (E F S A)",
number = "11",

}

RIS

TY - JOUR

T1 - Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97

T2 - (Scientific Opinion)

AU - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

AU - Sjödin, Anders Mikael

N1 - EFSA 2017 5057

PY - 2017/11/17

Y1 - 2017/11/17

N2 - Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on betaine as a novel food (NF) pursuant to Regulation (EC) No 258/97. The information provided on the composition, the specifications, the batch-to-batch variability, stability and production process of the NF is sufficient and does not raise concerns about the safety of the NF. The NF is proposed to be used in foods intended to meet additional requirements for intense muscular effort with a maximum intake of 2.5 g/day of betaine for sports people above 10 years of age. Based on the lowest BMDL05, which was derived from a chronic toxicity study in rats in which a dose-related increase in platelet counts was observed, and the anticipated daily intake of the NF in the target population, the Margins of Exposure are 3.6 and 5, which are generally regarded as not sufficient. However, the total exposure to betaine from the diet (about 830 mg/day) is not known to be associated with adverse effects. Moreover, no adverse effects on platelet counts were noted in human intervention studies with exposure levels of 4 g/day of betaine for up to 6 months. A significant increase in total and low-density lipoprotein (LDL)-cholesterol concentrations was noted at intakes of 4 g/day of betaine in overweight subjects with metabolic syndrome but not in healthy subjects, nor at intakes of 3 g/day. Thus, considering 4 g/day of betaineas a reference point and applying an uncertainty factor of 10 to account for interindividual variability, an amount of 400 mg/day of betaine in addition to the background exposure is considered as safe. The Panel considers that the NF is safe to be used at maximum intake of 400 mg/day in the target population.

AB - Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on betaine as a novel food (NF) pursuant to Regulation (EC) No 258/97. The information provided on the composition, the specifications, the batch-to-batch variability, stability and production process of the NF is sufficient and does not raise concerns about the safety of the NF. The NF is proposed to be used in foods intended to meet additional requirements for intense muscular effort with a maximum intake of 2.5 g/day of betaine for sports people above 10 years of age. Based on the lowest BMDL05, which was derived from a chronic toxicity study in rats in which a dose-related increase in platelet counts was observed, and the anticipated daily intake of the NF in the target population, the Margins of Exposure are 3.6 and 5, which are generally regarded as not sufficient. However, the total exposure to betaine from the diet (about 830 mg/day) is not known to be associated with adverse effects. Moreover, no adverse effects on platelet counts were noted in human intervention studies with exposure levels of 4 g/day of betaine for up to 6 months. A significant increase in total and low-density lipoprotein (LDL)-cholesterol concentrations was noted at intakes of 4 g/day of betaine in overweight subjects with metabolic syndrome but not in healthy subjects, nor at intakes of 3 g/day. Thus, considering 4 g/day of betaineas a reference point and applying an uncertainty factor of 10 to account for interindividual variability, an amount of 400 mg/day of betaine in addition to the background exposure is considered as safe. The Panel considers that the NF is safe to be used at maximum intake of 400 mg/day in the target population.

KW - Faculty of Science

KW - Betaine

KW - Novel food

KW - Ingredient

KW - Safety

U2 - 10.2903/j.efsa.2017.5057

DO - 10.2903/j.efsa.2017.5057

M3 - Journal article

VL - 15

JO - E F S A Journal

JF - E F S A Journal

SN - 1831-4732

IS - 11

M1 - 5057

ER -

ID: 188484098